Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00147485
Status:
TERMINATED
Last Update Posted:
2008-08-18
First Post:
2005-09-02
Brief Title:
A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-12
Start Date Type:
None
Primary Completion Date:
2007-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-02
First Submit QC Date:
September 2 2005
Study First Post Date:
2005-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-08-14
Last Update Post Date:
2008-08-18
Last Update Post Date Type:
ESTIMATED